PharVision Advisers »

Treace Med Concepts shares owned by PharVision Advisers

Quarter-by-quarter ownership of Treace Med Concepts (TMCI) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Treace Med Concepts

Tip: Access up to 7 years of quarterly data

All positions including Treace Med Concepts held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Treace Med Concepts by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $143k 19k 7.44

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Treace Med Concepts

Armistice Capital
BlackRock
William Blair Investment Management
Vanguard Group
Gagnon Securities
Millennium Management
Atlantic Trust
Jpmorgan Chase & Co
First Eagle Investment Management
Geode Capital Management
State Street Corporation
Gagnon Advisors
Deutsche Bank Aktiengesellschaft
Parkman Healthcare Partners
D. E. Shaw & Co

View all funds holding Treace Med Concepts